A San Diego-based biotech company is turning heads Tuesday morning after the company announced that its partner, Melinta Therapeutics, has launched Rezzayo, a treatment for...

To read the full story on AllPennyStocks.com, click here.

Cidara Therapeutics (NASDAQ:CDTX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Cidara Therapeutics.
Cidara Therapeutics (NASDAQ:CDTX)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Cidara Therapeutics.